Cardiff Oncology Inc. buy secretariat
Start price
19.09.20
/
50%
€7.40
Target price
23.09.20
-
Performance (%)
34.46%
End price
23.09.20
€9.95
Summary
This prediction ended on 23.09.20 with a price of €9.95. With a performance of 34.46% the BUY prediction by secretariat was a big success. secretariat has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | -3.009% | -3.009% | 22.515% | -62.920% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
According to secretariat what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by secretariat for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Buy beendet